Fluent Corp.
Fluent Corp.
Your view on CNTMF
Overview
What the company does, where it operates, and who runs it.
About Fluent Corp.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- David E. Vautrin
- Headquarters
- 82 North East 26th Street, Miami, FL, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- David E. Vautrin
- Headquarters
- 82 North East 26th Street, Miami, FL, US
Fluent Corp. is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania, New York and Texas. The Company operates under the Fluent brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves.
This is driven by Fluent's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Tampa, Florida. Fluent's common shares trade on the CSE under the symbol "TIUM.U" and on the OTCQB under the symbol "CNTMF."
For more information about the Company, please visit www.investors.getfluent.com.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Fluent Corp., and the rating behind it. CNTMF last traded at $0.04; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Fluent Corp.. Starting points for Fluent Corp.: EPS -$0.14, beta 0.83 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Fluent Corp.. Fluent Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Fluent Corp.. Trailing twelve-month EPS for Fluent Corp. stands at -$0.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Fluent Corp.. Fluent Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Fluent Corp. valued side by side against its closest peers. Fluent Corp. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Fluent Corp., and how their positions are changing. At a $18.3M market value, institutional positions materially move Fluent Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Fluent Corp. executives and directors. Shares of Fluent Corp. have traded between $0.03 and $0.09 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Fluent Corp.. Fluent Corp. is a $18.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Fluent Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Fluent Corp.. Coverage tracks Fluent Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.